WallStreetZenWallStreetZen

AnalystsDavid Nierengarten
David Nierengarten's Stock Forecasts

Analyst Ranking
Top 3%
#77 out of 3772 analysts
Average Return
+28.12%
Win Rate
51%30 out of 59
Risk vs Reward
Poor
Good

David Nierengarten's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
ANAPTYSBIO INCANAB
+405.93%$23.10$116.87
2017-03-09 -
2018-03-09
Buy
BEAM THERAPEUTICS INCBEAM
+300.96%$23.02$92.30
2020-03-02 -
2021-03-02
Buy
FATE THERAPEUTICS INCFATE
+291.11%$22.94$89.72
2020-04-03 -
2021-02-26
Buy
KARYOPHARM THERAPEUTICS INCKPTI
+287.27%$4.40$17.04
2019-02-27 -
2020-01-17
Buy
ENDOCYTE INCECYT
+188.44%$5.88$16.96
2017-10-03 -
2018-10-03
Buy

David Nierengarten's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
TURNING POINT THERAPEUTICS INCTPTX
1Hold$76.00+1.10%Downgrades
23 days ago
SPRINGWORKS THERAPEUTICS INCSWTX
1Buy$50.00+94.93%Maintains
a month ago
INOZYME PHARMA INCINZY
2Buy$25.00+392.13%Maintains
3 months ago
CODIAK BIOSCIENCES INCCDAK
1Buy$24.00+516.97%Maintains
4 months ago
FATE THERAPEUTICS INCFATE
6Buy$74.00+176.12%Upgrades
6 months ago
2SEVENTY BIO INCTSVT
1Buy$40.00+191.12%Initiates Coverage On
8 months ago
THESEUS PHARMACEUTICALS INCTHRX
1Buy$24.00+298.67%Initiates Coverage On
8 months ago
TCR2 THERAPEUTICS INCTCRR
1Hold$11.00+284.62%Downgrades
9 months ago
ARGENX SEARGX
7Buy$362.00-0.64%Maintains
a year ago
BEAM THERAPEUTICS INCBEAM
2Buy$149.00+250.51%Maintains
a year ago
INTELLIA THERAPEUTICS INCNTLA
3Hold$87.00+62.89%Maintains
a year ago
NOVOCURE LTDNVCR
3Sell$154.00N/ADowngrades
a year ago
CHIMERIX INCCMRX
1Buy$14.00N/AInitiates Coverage On
a year ago
ANAPTYSBIO INCANAB
4HoldN/AN/ADowngrades
a year ago
NUVATION BIO INCNUVB
1Buy$20.00N/AInitiates Coverage On
a year ago
MYOKARDIA INCMYOK
1Hold$225.00N/ADowngrades
2 years ago
FREELINE THERAPEUTICS HOLDINGS PLCFRLN
1Buy$28.00N/AInitiates Coverage On
2 years ago
FUSION PHARMACEUTICALS INCFUSN
1Buy$25.00N/AInitiates Coverage On
2 years ago
STEMLINE THERAPEUTICS INCSTML
3Hold$12.50N/ADowngrades
2 years ago
G1 THERAPEUTICS INCGTHX
2Buy$55.00N/AMaintains
2 years ago
KARYOPHARM THERAPEUTICS INCKPTI
4HoldN/AN/ADowngrades
2 years ago
IVERIC BIO INCISEE
1Buy$13.00N/AInitiates Coverage On
2 years ago
XENCOR INCXNCR
2Buy$44.00N/AMaintains
4 years ago
TESARO INCTSRO
3Hold$75.00N/ADowngrades
4 years ago
SPARK THERAPEUTICS INCONCE
2Hold$40.00N/AUpgrades
4 years ago
ULTRAGENYX PHARMACEUTICAL INCRARE
6Buy$88.00N/AMaintains
4 years ago
SUTRO BIOPHARMA INCSTRO
1Buy$20.00N/AInitiates Coverage On
4 years ago
AUDENTES THERAPEUTICS INCBOLD
1Buy$52.00N/AMaintains
4 years ago
FENNEC PHARMACEUTICALS INCFENC
2Buy$16.00N/AMaintains
4 years ago
ENDOCYTE INCECYT
3Buy$21.00N/AMaintains
4 years ago
VOYAGER THERAPEUTICS INCVYGR
2BuyN/AN/AUpgrades
4 years ago
BLUEPRINT MEDICINES CORPBPMC
1Buy$106.00N/AMaintains
4 years ago
SYROS PHARMACEUTICALS INCSYRS
1Buy$13.00N/AMaintains
4 years ago
PROTHENA CORP PUBLIC LTD COPRTA
1HoldN/AN/ADowngrades
5 years ago
KITE PHARMA INCKITE
2HoldN/AN/AUpgrades
5 years ago
JUNO THERAPEUTICS INCJUNO
1BuyN/AN/AUpgrades
5 years ago
CLEMENTIA PHARMACEUTICALS INCCMTA
1Buy$26.00N/AInitiates Coverage On
5 years ago
NOVAN INCNOVN
1HoldN/AN/ADowngrades
5 years ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.